Parkinson Disease (PD)NCT07821151
The Effect of Beechband on Parkinson's Symptoms
A study testing Beechband in people with Parkinson Disease (PD), run by University of Exeter at 1 site in United Kingdom.
Trial summary
Parkinson's disease can affect movement, balance, and everyday activities. The Beechband is a wrist-worn device that provides intermittent vibrations. Some people have reported improvements in symptoms while wearing the device, but there is currently little scientific evidence to support these reports. Read more about this study
- Who is it for?
- Any age
- Conditions the study is for
- Parkinson Disease (PD)
- What is being tested?
- Beechband
- Type of treatment
- Medical device
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 60 participants
- Where
- 1 siteUnited Kingdom
- Study dates
- 22 Apr 2026to 10 Nov 2026
- Phase
- Interventional
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages Any age
- All sexes
- No healthy volunteers
- Child, Adult, Older adult
Who may be able to join
- Diagnosis of idiopathic Parkinson's disease according to UK Parkinson's Disease Society Brain Bank criteria
- Able to participate in online video calls
Who cannot join
- Montreal Cognitive Assessment (MOCA) score below 16
- Previous use of a Beechband, or another vibrating wrist-worn device, for managing symptoms associated with Parkinson's disease
- Any neurological diagnosis other than Parkinson's disease that affects cognition or memory, pain, or movement
- Pregnant
- Significant memory problems that could interfere with the ability to provide informed consent
- Unable to stand or walk without assistance for at least 1 minute
- Any electronic implant, including deep brain stimulation or a pacemaker
Trial locations and contacts
1 site in 1 country.
About this study
Official title: Evaluating Potential Changes in Symptoms Associated With Parkinson's After 6-12 Weeks of Wearing the Beechband
Parkinson's disease can affect movement, balance, and everyday activities. The Beechband is a wrist-worn device that provides intermittent vibrations. Some people have reported improvements in symptoms while wearing the device, but there is currently little scientific evidence to support these reports.
This pilot study will explore whether movement symptoms and participants' perceptions of their symptoms change after wearing the Beechband for 6 or 12 weeks. Approximately 60 people with Parkinson's disease will be randomly assigned to one of two groups. One group will wear the Beechband for 12 weeks. The other group will continue their usual activities without the Beechband for the first 6 weeks and will then wear it for the following 6 weeks. Participants will be asked to wear the device for approximately 6 hours each day during their assigned wearing period.
Read more
Assessments will be conducted remotely by video call at the beginning of the study and after 6 and 12 weeks. They will include measures of movement and balance, a timed walking task, and questionnaires about symptoms and everyday experiences. Device use and any unwanted or unexpected effects will also be recorded.
The study is intended to estimate the size of any possible changes and assess the feasibility of a future larger clinical trial. It is not designed to provide definitive evidence that the Beechband is effective.
- Conditions
- Parkinson Disease (PD)
- Being tested
- Beechband
- Keywords
- Parkinson's Disease, Vibrotactile stimulation, Wearable device
- Medical subject headings
- Parkinson Disease
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
BeechbandDevice
The Beechband is a wrist-worn device that delivers intermittent vibrotactile stimulation. Participants are instructed to wear the device for approximately 6 hours per day during their assigned intervention period, following the manufacturer's guidance.
Arm 1: Participants in the IMMEDIATE start arm wear the device for 12 weeks. Arm 2: Participants in the DELAYED start arm wear the device during Weeks 6-12.
During selected remote assessments following a Beechband wearing period, movement measures are completed with the device switched on and switched off.
| Study group | Role | What they receive |
|---|---|---|
| Immediate Start Beechband | Experimental | Participants wear the Beechband for approximately 6 hours per day throughout the 12-week study period. Receives: Device: Beechband |
| Delayed Start Beechband | Experimental | Participants continue their usual activities without wearing the Beechband during the first 6 weeks. They then wear the Beechband for approximately 6 hours per day during Weeks 6-12. Receives: Device: Beechband |
What is being measured
The primary outcome is the main question the study is designed to answer.
Modified Unified Parkinson's Disease Rating Scale Motor Score (Modified UPDRS)
Motor symptoms are assessed remotely using the Unified Parkinson's Disease Rating Scale. Items that cannot be assessed reliably by video, including rigidity and postural instability, are omitted. Retained items are scored and summed, with higher scores indicating more severe motor symptoms. Assessments following a Beechband-wearing period also include measurements with the device switched on and switched off.
Measured: Baseline, Week 6, and Week 12
Secondary outcomes (5)
Timed Up and Go Test Completion Time
Time in seconds required to stand from a chair, walk 3 metres, turn, return, and sit down. A shorter time indicates better functional mobility.
Measured: Baseline, Week 6, and Week 12
Falls Efficacy Scale - International (FES-I)
Self-reported concern about falling during everyday activities. Higher scores indicate greater concern about falling.
Measured: Baseline, Week 6, and Week 12
Visual Sensitivity Scale (VSS)
Self-reported symptoms associated with visually complex or moving environments
Measured: Baseline, Week 6, and Week 12
Gait Specific Attentional Profile (G-SAP)
Self-reported attention directed toward walking and movement.
Measured: Baseline, Week 6, and Week 12
Generalised Anxiety Scale (GAD-7)
Seven-item measure of anxiety symptoms, ranging from 0 to 21; higher scores indicate greater anxiety.
Measured: Baseline, Week 6, and Week 12
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted15 Sep 2026
- Study start22 Apr 2026
- Primary completion10 Nov 2026 (estimated)
- Study completion10 Nov 2026 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Parkinson Disease (PD)Studies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Single blind
- Who is masked
- Outcomes assessor
- Enrolment
- 60 participants (estimated)
Sponsor and investigators
- Lead sponsor
- University of Exeter
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07821151
- Sponsor's protocol ID
- 12094209
- Status last verified
- Sep 2026
- First submitted
- 9 Sep 2026
- Last updated
- 15 Sep 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- Yes: Fully anonymised individual participant data supporting the published study findings will be shared through the Open Science Framework. Shared data may include motor-assessment scores, functional mobility outcomes, physical activity measures, and information about device use and adverse events. Names, contact information, dates of birth, postal addresses, linking information, questionnaire responsese and video recordings will not be shared. Supporting materials, including a data dictionary, study protocol, and relevant analysis information, will be provided where possible. Data will be made available following completion of the study and publication of the main findings, anticipated by December 2027. The repository record and web address will be added when available. Access will be open, subject to the repository's terms and the reuse licence applied to the dataset.
Study at a glance
From the registry record, last updated by the sponsor on 15 Sep 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Evaluating Potential Changes in Symptoms Associated With Parkinson's After 6-12 Weeks of Wearing the Beechband
- ClinicalTrials.gov ID
- NCT07821151
- Acronym / sponsor ID
- 12094209
- Conditions
- Parkinson Disease (PD)
- Keywords
- Parkinson's Disease, Vibrotactile stimulation, Wearable device
- Study type
- Interventional
- Recruitment status
- Active, not recruiting
- Enrolment
- 60 participants (estimated)
- Lead sponsor
- University of ExeterUniversity, hospital or other
- Study start
- 22 Apr 2026 (actual)
- Primary completion
- 10 Nov 2026 (estimated)
- Study completion
- 10 Nov 2026 (estimated)
- First posted
- 15 Sep 2026 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Parkinson's disease can affect movement, balance, and everyday activities. The Beechband is a wrist-worn device that provides intermittent vibrations. Some people have reported improvements in symptoms while wearing the device, but there is currently little scientific evidence to support these reports.
This pilot study will explore whether movement symptoms and participants' perceptions of their symptoms change after wearing the Beechband for 6 or 12 weeks. Approximately 60 people with Parkinson's disease will be randomly assigned to one of two groups. One group will wear the Beechband for 12 weeks. The other group will continue their usual activities without the Beechband for the first 6 weeks and will then wear it for the following 6 weeks. Participants will be asked to wear the device for approximately 6 hours each day during their assigned wearing period.
Assessments will be conducted remotely by video call at the beginning of the study and after 6 and 12 weeks. They will include measures of movement and balance, a timed walking task, and questionnaires about symptoms and everyday experiences. Device use and any unwanted or unexpected effects will also be recorded.
The study is intended to estimate the size of any possible changes and assess the feasibility of a future larger clinical trial. It is not designed to provide definitive evidence that the Beechband is effective.
Study design
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Single blind (outcomes assessor)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| Immediate Start Beechband | Experimental | Device: BeechbandParticipants wear the Beechband for approximately 6 hours per day throughout the 12-week study period. |
| Delayed Start Beechband | Experimental | Device: BeechbandParticipants continue their usual activities without wearing the Beechband during the first 6 weeks. They then wear the Beechband for approximately 6 hours per day during Weeks 6-12. |
Who may qualify
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Child, Adult, Older adult
Key inclusion criteria (2 listed)
- Diagnosis of idiopathic Parkinson's disease according to UK Parkinson's Disease Society Brain Bank criteria
- Able to participate in online video calls
Key exclusion criteria (7 listed)
- Montreal Cognitive Assessment (MOCA) score below 16
- Previous use of a Beechband, or another vibrating wrist-worn device, for managing symptoms associated with Parkinson's disease
- Any neurological diagnosis other than Parkinson's disease that affects cognition or memory, pain, or movement
- Pregnant
- Significant memory problems that could interfere with the ability to provide informed consent
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| BeechbandThe Beechband is a wrist-worn device that delivers intermittent vibrotactile stimulation. Participants are instructed to wear the device for approximately 6 hours per day during their assigned intervention period, following the manufacturer's guidance. Arm 1: Participants in the IMMEDIATE start arm wear the device for 12 weeks. Arm 2: Participants in the DELAYED start arm wear the device during Weeks 6-12. During selected remote assessments following a Beechband wearing period, movement measures are completed with the device switched on and switched off. | Device | Delayed Start Beechband, Immediate Start Beechband |
Primary outcome
Modified Unified Parkinson's Disease Rating Scale Motor Score (Modified UPDRS)
Time frame: Baseline, Week 6, and Week 12
Motor symptoms are assessed remotely using the Unified Parkinson's Disease Rating Scale. Items that cannot be assessed reliably by video, including rigidity and postural instability, are omitted. Retained items are scored and summed, with higher scores indicating more severe motor symptoms. Assessments following a Beechband-wearing period also include measurements with the device switched on and switched off.
5 secondary outcomes
Timed Up and Go Test Completion Time
Time frame: Baseline, Week 6, and Week 12
Falls Efficacy Scale - International (FES-I)
Time frame: Baseline, Week 6, and Week 12
Visual Sensitivity Scale (VSS)
Time frame: Baseline, Week 6, and Week 12
Gait Specific Attentional Profile (G-SAP)
Time frame: Baseline, Week 6, and Week 12
Generalised Anxiety Scale (GAD-7)
Time frame: Baseline, Week 6, and Week 12
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 15 Sep 2026.
- Individual participant dataSharing planned: Yes. Fully anonymised individual participant data supporting the published study findings will be shared through the Open Science Framework. Shared data may include motor-assessment scores, functional mobility outcomes, physical activity measures, and information about device use and adverse events. Names, contact information, dates of birth, postal addresses, linking information, questionnaire responsese and video recordings will not be shared. Supporting materials, including a data dictionary, study protocol, and relevant analysis information, will be provided where possible. Data will be made available following completion of the study and publication of the main findings, anticipated by December 2027. The repository record and web address will be added when available. Access will be open, subject to the repository's terms and the reuse licence applied to the dataset.
Related trials for Parkinson Disease (PD)
RecruitingPhase 3
A Clinical Study of Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) as First-line Maintenance Treatment of Cervical Cancer (MK-2870-036/TroFuse-036/GOG-3123/ENGOT-cx22)
Cervical Cancer
Active, not recruitingPhase 1/2
Clinical Safety and Efficacy of Umbilical Cord Mesenchymal Stromal Cells-derived Exosomes in Patients With Parkinson's Disease
Parkinson Disease (PD)
Active, not recruitingObservational study
Adaptive DBS to Offset STN Dysregulation During Exercise in PD
Parkinson Disease
Not yet recruiting
Evaluating the Effect of the Zeen Mobility Device on Clinical Practicality, Safety, and Impact (Via Assessments of Walking, Standing Tolerance, Balance, Endurance, Effort, and Participation in Daily Tasks) in an Outpatient Rehabilitation Setting for Individuals With Mobility Impairments.
Stroke, Parkinson's Disease (PD)
Active, not recruitingPhase 2
A Study of Investigational Agents in Participants With Previously Treated Stage IV Nonsquamous Non-small Cell Lung Cancer (NSCLC) (MK-3475-01H/KEYMAKER-U01)
Carcinoma, Non-Small-Cell Lung
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
The record lists no contact. Use the official record to reach the sponsor.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Beechband in people with Parkinson Disease (PD), run by University of Exeter at 1 site in United Kingdom.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 2 inclusion and 7 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: under way, not looking for participants, as of the sponsor's last update on 15 Sep 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in United Kingdom. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Modified Unified Parkinson's Disease Rating Scale Motor Score (Modified UPDRS) (time frame: Baseline, Week 6, and Week 12). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 15 Sep 2026.